Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Victory Square Technologies Inc
C.VST
Alternate Symbol(s):
VSQTF
Financial Services
Asset Management
Blockchain
Victory Square Technologies Inc. is a Canada-based venture builder that provides investors a liquid way to invest in early-stage technology companies without buying a venture fund that requires accredited investor status or multi-year commitments. The Company has a diverse portfolio of approximately 25+ companies that are engaged in verticals, including artificial intelligence (AI), machine learning (ML), blockchain/Web3, virtual and augmented reality (VR/AR), gaming, climate tech, creator economy, digital health, and others. The Company is committed to organizations that provide services in the youth, mental health, special needs, sport, tech, education, marginalized groups, first nations, and accessibility sectors. The Company’s subsidiaries include VS Digital Health Inc., Hydreight Canada Holdings Inc., IV Hydreight Inc., Hydreight Technologies Inc., Futura Health & Wellness Inc., Draft Label Technologies Inc., XR Immersive Tech Inc. and others.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
CSE:VST - Post by User
Victory Square Technologies Inc
Bullboard Posts
(120)
•••
CamaroZL1
X
View Profile
View Bullboard History
Comment by
CamaroZL1
on Oct 13, 2020 4:30pm
88 Views
Post# 31708832
RE:RE:RE:RE:RE:RE:RE:RE:VST Late???
RE:RE:RE:RE:RE:RE:RE:RE:VST Late???
You shorted the uptrend plain and simple. Couldnt even break the 5min. Antibody/Antigen it dont matter see you at 75 cents. Double down. Then i see you at 92. Fact is you are the weak.
Comment on this Post
Bullboard Posts
Invest wiser with BMO's InvestorLine Platform features
A potential breakthrough in spinal cord and optic nerve injury treatment
Eminent acquires promising Nevada gold project
Global Tungsten Market and Supply Security
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
New research report on Nextech3D.AI by H.C. Wainwright & Co.
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide
Debt-Free Cannabis Company Set for Next Stage of Growth
A potential breakthrough in spinal cord and optic nerve injury treatment